2Chakraborty S,Khuranan,Sharma JB,et al.Endometrial hormone r-eceptors in women with dysfunctional uterine bleeding[J].ArchGynecol Obstet,2005,272(1):17-22.
8Zervous S,Klentzeris LD,Old RW.Nitric oxide synthase expressionand steroid regulation in the uterus of women with menorrhagia[J].Mol Hum Reprod,1999,5(ll):1048-1054.
10Ryan BM,Konecny GE,Kahiert S,et al.Survivin expression inbreast cancer predicts clinical outcome and is associated withHER2,VEGF,urokinase plasminogen activator and PAI-I[J].Annals of Oncology,2006,17(4):597.
5Kokawa K,Shikone T,Nakano R.Apoptosis in the human uterine endometrium during the menstrual cycle[J].J Clin Endocrinol Metab,1996,81(11):4144-4147.
6Thomas S,Quinn BA,Das SK,et al.Targeting the bcl-2 family for cancer therapy[J].Expert Opin Ther Targets,2013,17(1):61-75.
7Sweet MG,Schmidt-Dalton TA,Weiss PM,et al.Evaluation and management of abnormal uterine bleeding in premenopausal women[J].Am Fam Physician,2012,85(1):35-43.
8Damle RP,Dravid NV,Suryawanshi KH,et al.Clinicopathological spectrum of endometrial changes in perimenopausal and post-menopausal abnormal uterine bleeding:a 2 years study[J].J Clin Diagn Res,2013,7(12):2774-2776.
9Matteson KA,Anderson BL,Pinto SB,et al.Practice patterns and attitudes about treating abnormal uterine bleeding:a national survey of obstetricians and gynecologists[J].Am J Obstet Gynecol,2011,205(4):1-8.
